Autoimmune Disease and Dental Implants: What the Evidence Shows

Overview

Autoimmune disease covers a wide range of conditions with very different impacts on the oral environment and on implant healing. The literature is heterogeneous, but the general finding is that well-controlled autoimmune disease — including rheumatoid arthritis and lupus — does not categorically preclude implants, and survival rates are within the broad range reported for the general population^[1].

Common conditions and what they change

• Sjögren's syndrome: reduced saliva flow elevates caries and peri-implant mucositis risk. Aggressive caries control on remaining teeth and meticulous hygiene are critical.
• Rheumatoid arthritis: manual dexterity may limit oral hygiene; methotrexate and biologics modify healing. Survival data are reassuring overall.
• Systemic lupus erythematosus: when stable and not on high-dose steroids, implants are generally feasible. Active flares are a contraindication to elective surgery.
• Scleroderma: reduced mouth opening and microstomia create access challenges; surgical planning must be realistic about working space.
• Inflammatory bowel disease (Crohn's, ulcerative colitis): immunosuppression and steroid use are the main considerations.

Immunosuppressants and implant healing

Chronic corticosteroids impair wound healing and may slightly elevate infection risk. Biologics (TNF-α inhibitors, IL-6 blockers, JAK inhibitors) have a heterogeneous evidence base; most rheumatology societies suggest continuing them around minor oral surgery unless the patient is on a particularly immunosuppressive regimen. Methotrexate at osteoporosis doses has not been shown to impair implant outcomes in the available data. As always, coordinate any change in disease-modifying therapy with the prescribing physician.

Practical approach

• Document disease, medications, and most recent disease-activity assessment.
• Schedule elective surgery during periods of disease quiescence.
• For Sjögren's patients, plan saliva-substitute use and tighter caries / peri-implant maintenance.
• For limited mouth opening (scleroderma), confirm surgical access realistically before committing to posterior implants.
• 3–4 month maintenance recall is reasonable for most autoimmune patients.

Frequently asked questions

Related reading

• Diabetes and implants
• Peri-implantitis treatment
• Risks and complications